The liver stores excess glucose, sugar, in the form of glycogen—chains of glucose—, which is later released to cover body energy requirements.
Research Programmes / Core Facilities
Cell and Developmental Biology
Structural and Computational Biology
Chemistry and Molecular Pharmacology
Core Facilities & Services
Scientists at IRB Barcelona are supported by an extensive range of common core facilities that provide state-of-the-art technologies and scientific services. These facilities are a key asset for our research, allowing the Institute to obtain outstanding results. They are designed to incorporate the most novel technologies available and provide them to our researchers in the shortest time possible.
Selected IRB Barcelona publications
IRB Barcelona's partnerships, with organisations in areas of mutual interest and expertise, aim to take advantage of the wealth of knowledge, resources and technologies so critical to advancing the field of biomedicine
News & Events
Researchers at IRB Barcelona discover that the liver and brain communicate in order to regulate appetite
A mechanism that allows a differentiated cell to reactivate as a stem cell revealed
Flies with colon cancer help to unravel the genetic keys to disease in humans
Laying siege to beta-amyloid, the key protein in Alzheimer’s disease
26Nov“Searching surface mutationswith higher thermostabilityinthe prokaryotic LAT transporter Asc-like”
28NovStem cells in aging and disease
09DecBiostatistics / Bioinformatics Unit: Get started on Experimental Design and Data Analysis
12DecTargeting replicative stress in cancer therapy
One kind of stem cell, those referred to as ‘facultative’, form part—together with other cells—of tissues and organs. There is apparently nothing that differentiates these cells from the others.
Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have managed to generate a fruit fly (Drosophila melanogaster) model that reproduces human colon cancer.
The peptide —a small protein— beta-amyloid is strongly associated with Alzheimer’s disease; however, researchers are still looking for unequivocal proof that this peptide is the causal agent of the
Speaker: Dr. Pura Muñoz-Cánoves
Pompeu Fabra University (Barcelona) & ICREA
Speaker: Oskar Fernandez-Capetillo, PhD
HHMI International Early Career Scientist, Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain